Flag of the European Union EU Clinical Trials Register Help

Clinical trials for General sense

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44336   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    38 result(s) found for: General sense. Displaying page 1 of 2.
    1  2  Next»
    EudraCT Number: 2007-001677-28 Sponsor Protocol Number: 2007/08 Start Date*: 2007-11-28
    Sponsor Name:Charité - Universitätsmedizin Berlin
    Full Title: Quantification of the anesthetic effect of nitrous oxide using intravenous "closed-loop" anesthesia
    Medical condition: This is a study of the anesthetic effect of the IMP, nitrous oxide. In this sense "general anesthesia" can be termed the medical condition under investigation.
    Disease:
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed) FR (Completed) BE (Completed)
    Trial results: View results
    EudraCT Number: 2020-000396-20 Sponsor Protocol Number: Dropizol_2020 Start Date*: 2021-01-02
    Sponsor Name:Mech-Sense, Aalborg University Hospital
    Full Title: Opium tincture against chronic diarrhea - Patients: An investigator initiated, randomized placebo-controlled, clinical trial
    Medical condition: Chronic diarrhea
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004856 10066556 Chronic diarrhea LLT
    Population Age: Adults Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2020-000195-38 Sponsor Protocol Number: D3252C00004 Start Date*: 2020-11-18
    Sponsor Name:AstraZeneca AB
    Full Title: A Multicentre, Randomised, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study of Benralizumab for the Prevention of Recurrence of Nasal Polyps Following Surgical Rem...
    Medical condition: Nasal polyposis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004855 10028754 Nasal polyp LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended) HU (Prematurely Ended) PL (Prematurely Ended) BE (Prematurely Ended) DE (Prematurely Ended) AT (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2017-000732-34 Sponsor Protocol Number: ABOXY_2017 Start Date*: 2017-06-21
    Sponsor Name:Mech-Sense, Dept. Gastroenterology & Hepatology, Aalborg University Hospital
    Full Title: Oral Controlled Release Formulations to Patients with Gastrointestinal Dysfunction – Is the Release of Drug and the Absorption Impaired?
    Medical condition: Healthy (pain) and patients (pain).
    Disease: Version SOC Term Classification Code Term Level
    20.1 100000004856 10009093 Chronic pancreatitis LLT
    20.0 100000004861 10012594 Diabetes LLT
    20.0 100000004856 10048516 Gastrointestinal disorder (NOS) LLT
    20.0 100000004865 10050554 Gastric bypass NOS LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2017-003675-61 Sponsor Protocol Number: D3252C00001 Start Date*: 2017-12-21
    Sponsor Name:AstraZeneca AB
    Full Title: A Multicenter, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Phase 3 Efficacy and Safety Study Of Benralizumab in Patients with Severe Nasal Polyposis
    Medical condition: Nasal polyposis
    Disease: Version SOC Term Classification Code Term Level
    20.0 100000004855 10028754 Nasal polyp LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Completed) AT (Completed) BE (Completed) HU (Completed) PL (Completed) DE (Completed)
    Trial results: View results
    EudraCT Number: 2013-003357-17 Sponsor Protocol Number: Ketamin_SST01 Start Date*: 2013-11-01
    Sponsor Name:Prof. Asbjørn Mohr Drewes
    Full Title: RESET Trial A randomized, double-blinded, single-centre, parallel-group, placebo-controlled, prospective trial of S-ketamine for pain treatment in chronic pancreatitis (RESET trial)
    Medical condition: Chronic Pancreatitis
    Disease: Version SOC Term Classification Code Term Level
    17.1 100000004856 10009093 Chronic pancreatitis LLT
    17.1 100000004856 10033646 Acute and chronic pancreatitis HLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2013-003176-12 Sponsor Protocol Number: A-93-52030-279 Start Date*: 2014-08-27
    Sponsor Name:IPSEN S.p.A
    Full Title: A PHASE II, MULTICENTRE, RANDOMIZED CONTROLLED STUDY EVALUATING THE QUALITY OF LIFE IN PATIENTS WITH INOPERABLE MALIGNANT BOWEL OBSTRUCTION TREATED WITH LANREOTIDE AUTOGEL 120 MG IN COMBINATION WIT...
    Medical condition: Inoperable malignant bowel obstruction
    Disease: Version SOC Term Classification Code Term Level
    17.0 10017947 - Gastrointestinal disorders 10061974 Gastrointestinal obstruction PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2011-002778-21 Sponsor Protocol Number: ESTEVE-SACO4-201 Start Date*: 2012-01-12
    Sponsor Name:Laboratorios del Dr. Esteve, S.A
    Full Title: A randomized, double-blind, controlled with active treatment (tramadol 100 mg) and placebo, parallel groups, Phase II clinical trial to establish the effective dose between 4 strengths of E-58425 f...
    Medical condition: Adult patients with moderate to severe dental pain
    Disease: Version SOC Term Classification Code Term Level
    14.0 10018065 - General disorders and administration site conditions 10033371 Pain PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2020-000233-41 Sponsor Protocol Number: OPTION Start Date*: 2020-08-25
    Sponsor Name:Sahlgrenska University Hospital
    Full Title: Labour induction in an outpatient setting - a multicenter randomized controlled trial. OPTION - OutPatienT InductiON
    Medical condition: Induction of labour
    Disease:
    Population Age: In utero, Under 18, Adults Gender: Male, Female
    Trial protocol: SE (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2013-003310-40 Sponsor Protocol Number: 1SPR11002 Start Date*: 2014-01-27
    Sponsor Name:Luitpold Pharmaceuticals, Inc.
    Full Title: A Single Arm, Open Label Study of the Safety, Efficacy, and Pharmacokinetics of SPRIX® (intranasal ketorolac tromethamine) in 0 to 11 year-Old Patients Undergoing Open Surgical Procedures
    Medical condition: post open surgery pain (incuding but not limited to orthopedic, abdominal, thoracic, plastic/reconstructive, neurologic [spine], or urologic procedures)
    Disease: Version SOC Term Classification Code Term Level
    18.0 10018065 - General disorders and administration site conditions 10033371 Pain PT
    Population Age: Newborns, Infants and toddlers, Children, Under 18 Gender: Male, Female
    Trial protocol: PL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2008-002653-21 Sponsor Protocol Number: C-2005-036-01 Start Date*: 2008-09-01
    Sponsor Name:Janssen-Cilag International NV, Turnhoutseweg 30, 2340 Beerse, Belgium
    Full Title: Number of Doses and Time to Onset Of Pain Relief (Analgesic Effect) Using the IONSYS™ System [Fentanyl Iontophoretic Transdermal System (40 µg)]
    Medical condition: Patients who experience moderate to severe pain and required opioid analgesia for 24 hours immediately following non laparoscopic total abdominal hysterectomy surgery
    Disease: Version SOC Term Classification Code Term Level
    9.1 10033371 Pain LLT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: BE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2013-000938-35 Sponsor Protocol Number: 1SPR11001 Start Date*: 2013-06-22
    Sponsor Name:Luitpold Pharmaceuticals, Inc.
    Full Title: A Single Arm, Open Label Study to compare the Pharmacokinetics, Safety, and Efficacy of SPRIX® (intranasal ketorolac tromethamine) in 12 to 17 Year-Old Patients vs. Adult Patients (18 - 64 Years) U...
    Medical condition: post open surgery pain (incuding but not limited to orthopedic, abdominal, thoracic, plastic/reconstructive, neurologic [spine], or urologic procedures)
    Disease: Version SOC Term Classification Code Term Level
    14.1 10018065 - General disorders and administration site conditions 10033371 Pain PT
    Population Age: Adolescents, Under 18, Adults Gender: Male, Female
    Trial protocol: PL (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-001133-18 Sponsor Protocol Number: PH-2006-1 Start Date*: 2006-05-25
    Sponsor Name:Pharmos Corp.
    Full Title: CANNABINOR DENTAL IMPACTION PAIN STUDY PROOF-OF-CONCEPT DOSE-RANGING STUDY
    Medical condition: Cannabinor is as an analgesic and anti-inflammatory agent. By its nature, it has been designed to be more active at the CB2 peripheral receptors and have less activity at the central CB1 receptors....
    Disease: Version SOC Term Classification Code Term Level
    8.1 10033371 Pain LLT
    Population Age: Adults Gender: Male
    Trial protocol: GB (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-005668-21 Sponsor Protocol Number: NL0605 Start Date*: 2007-03-22
    Sponsor Name:Reckitt Benckiser Healthcare International Limited
    Full Title: A randomised, double-blind, parallel group, multiple-dose 3 month study of ibuprofen 400mg alone, paracetamol (acetaminophen) 1000mg alone, ibuprofen 200mg plus paracetamol 500mg and ibuprofen 400m...
    Medical condition: Pain.
    Disease: Version SOC Term Classification Code Term Level
    8.1 10033371 Pain LLT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2009-015397-35 Sponsor Protocol Number: KF5503/53 Start Date*: 2010-02-12
    Sponsor Name:Grünenthal GmbH
    Full Title: A multicenter, open-label trial to assess cognitive and psychomotor performance as surrogate parameters for driving ability under stable long term treatment with tapentadol hydrochloride prolonged-...
    Medical condition: Pain
    Disease: Version SOC Term Classification Code Term Level
    14.0 10018065 - General disorders and administration site conditions 10033371 Pain PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2021-000137-14 Sponsor Protocol Number: PDC-01-0206 Start Date*: 2021-05-04
    Sponsor Name:Cessatech A/S
    Full Title: Pharmacokinetic study of intranasal CT001 in children 1-17 years of age undergoing elective surgical procedures
    Medical condition: Management of acute pain in children 1-17 years with the objective of preventing pain and distress associated with painful medical procedures in children.
    Disease: Version SOC Term Classification Code Term Level
    20.0 10018065 - General disorders and administration site conditions 10033371 Pain PT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2022-002923-37 Sponsor Protocol Number: 2022-ENT-FESS-nonFESS Start Date*: 2023-04-25
    Sponsor Name:Department of Otorhinolaryngology Head & Neck and Audiology, Rigshospitalet, Copenhagen, Denmark
    Full Title: Optimisation of treatment in patients with CRSwNP. An RCT of mepolizumab and surgical treatment with FESS and mepolizumab versus only mepolizumab over a 6- and 12-month follow-up
    Medical condition: Chronic rhinosinusitis with nasal polyps (CRSwNP) and asthma
    Disease: Version SOC Term Classification Code Term Level
    20.1 10038738 - Respiratory, thoracic and mediastinal disorders 10080060 Chronic rhinosinusitis with nasal polyps PT
    20.0 10038738 - Respiratory, thoracic and mediastinal disorders 10003553 Asthma PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: DK (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2015-000992-28 Sponsor Protocol Number: KCT04/2015-DORETAonko/SI Start Date*: 2015-07-15
    Sponsor Name:Krka, d.d., Novo mesto
    Full Title: A comparison of the severity of acute pain and the frequency of chronic pain after post-operative analgesia of lower and higher intensity following surgical emptying of the axillary gland in breast...
    Medical condition: Acute pain after surgical emptying of the axillary gland in breast cancer patients.
    Disease: Version SOC Term Classification Code Term Level
    18.0 10018065 - General disorders and administration site conditions 10033371 Pain PT
    Population Age: Adults, Elderly Gender: Female
    Trial protocol: SI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2014-005416-42 Sponsor Protocol Number: KF001 Start Date*: 2015-05-08
    Sponsor Name:Uppsala University. Department of Women's and children's health
    Full Title: Clondine in repeated doses for children in pain - a farmacokinetic study
    Medical condition: Pain in children
    Disease: Version SOC Term Classification Code Term Level
    18.0 10018065 - General disorders and administration site conditions 10033371 Pain PT
    Population Age: Infants and toddlers, Children, Adolescents, Under 18 Gender: Male, Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2015-000944-41 Sponsor Protocol Number: FenS-FenD Start Date*: 2015-04-20
    Sponsor Name:FONDAZIONE IRCCS "ISTITUTO NAZIONALE DEI TUMORI"
    Full Title: A PILOT STUDY TO TEST THE FEASIBILITY OF A TWO-ARM, DOUBLE BLIND, PARALLEL-GROUP, RANDOMIZED CONTROLLED TRIAL FOR THE COMPARISON OF THE DURATION OF THE ANALGESIC EFFICACY OF A SINGLE MATRIX TRANSDE...
    Medical condition: Patients with oncological pain
    Disease: Version SOC Term Classification Code Term Level
    20.0 10018065 - General disorders and administration site conditions 10033371 Pain PT
    Population Age: Adults, Elderly Gender: Male, Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Wed May 21 08:38:17 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA